SCHEMBL4873426

SCHEMBL4873426

COc1cccc(S(=O)(=O)Nc2ccc(SC3CCN(C)CC3)cc2)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 5/20 0.55
ALDH1A1 P00352 4/20 0.53
PKM P14618 2/20 0.53
TRIM24 O15164 2/20 0.53
BRD4 O60885 1/20 0.52
HDAC3 O15379 1/20 0.49
HDAC4 P56524 1/20 0.49
HDAC1 Q13547 1/20 0.49
HDAC7 Q8WUI4 1/20 0.49
HDAC2 Q92769 1/20 0.49
HDAC10 Q969S8 1/20 0.49
HDAC11 Q96DB2 1/20 0.49
HDAC8 Q9BY41 1/20 0.49
HDAC6 Q9UBN7 1/20 0.49
HDAC9 Q9UKV0 1/20 0.49
HDAC5 Q9UQL6 1/20 0.49
RORA P35398 1/20 0.49
RORC P51449 1/20 0.49
NR1H2 P55055 1/20 0.49
CYP11B1 P15538 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6617076 0.87 ALDH1A1 (0.60) PGRALDH1A1PKMTRIM24LMNA
SCHEMBL4870984 0.85 PGR (0.48) PGRPKMBRD4
SCHEMBL4866404 0.83 HTR6 (0.55) PGRALDH1A1PKMHDAC3HDAC4
SCHEMBL4873364 0.82 HTR6 (0.56) PGRTRIM24BRD4
SCHEMBL4868720 0.79 MAPT (0.49) PGRALDH1A1PKMHDAC3HDAC4
SCHEMBL4874458 0.78 ALDH1A1 (0.44) ALDH1A1TRIM24LMNASMN1; SMN2
SCHEMBL4866321 0.78 ALDH1A1 (0.57) ALDH1A1LMNAGAASMN1; SMN2
SCHEMBL4868699 0.78 TRIM24 (0.51) ALDH1A1PKMTRIM24BRD4LMNA
SCHEMBL4870783 0.78 SLC40A1 (0.44) ALDH1A1PKMTRIM24LMNASMN1; SMN2
SCHEMBL4876689 0.78 CES1 (0.54) ALDH1A1PKMHDAC3HDAC4HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7408067-B2 Aza-cyclic compounds as modulators of acetylcholine receptors MERCK + CO., INC. (US) 2008-08-05 US disclosed
US-20050070520-A1 Aza-cyclic compounds as modulators of acetylcholine receptors MERCK SHARP & DOHME CORP. 2005-03-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050070520-A1 Aza-cyclic compounds as modulators of acetylcholine receptors CHRNG, CHRNA4, CHRNB4 PGR 1466/4885ALDH1A1 1088/4885PKM 4341/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.